A recent study identified the alternative complement pathway as a key mediator of PAH using both samples from PAH patients as well a mouse model of pulmonary hypertension in mice deficient for various complement factors, C3, C5 and factor H [139]. The gene discussed is CFH; the disease is pulmonary arterial hypertension.